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INTRODUCTION
Hydrogen fluoride (HF) is a weak acid existing as an associated molecule up to H 6 F 6 at 1 atm with temperatures of ,100°C; under these conditions, the average molecular weight of the molecules is 50-55 Daltons [Stokinger, 1981] . It is infinitely soluble in cold water [Handbook of Physics and Chemistry, 1978] and fumes strongly in moist air [Stokinger, 1981] .
HF is used in a variety of industrial processes involving brick, glass, ceramics, plastics, aluminum, ferroenamels, fluorocarbons, aerosols, welding, coal burning, rocket engine fuels, high octane fuels, silicone wafer etching, dental laboratories, ore extraction processes, phosphate fertilizers, insecticides, and cleaning agents [Caravati, 1988; Dieffenbacher and Thompson, 1962; MacKinnon, 1988; Mayer and Gross, 1985; Stokinger, 1981; Waldbott and Lee, 1978] . HF is usually produced by interaction of calcium fluoride (fluorspar) and sulfuric acid [MacKinnon, 1988] . For HF gas, the American Conference of Governmental Industrial Hygienists ceiling limit is 3 ppm as F [ACGIH, 1994] . The Occupational Safety and Health Administration's Permissible Exposure Limit and National Institute for Occupational Safety and Health's Recommended Exposure Level are both 3 ppm as well. The NIOSH Immediately Dangerous to Life and Health Level is 30 ppm [Alexeeff et al., 1993] .
Most literature related to HF injury pertains to dermal contact. Inhalation injury due to HF has usually occurred in industrial and laboratory settings, although at least one forensic case has been documented [Chela et al., 1989] . Almost all documented cases resulting in significant pulmonary pathology have occurred following massive exposures [Braun et al., 1984; Caravati, 1988; Greendyke and Hodge, 1964; MacKinnon, 1988; Mayer and Guelich, 1963; Sadove et al., 1990; Trevino et al., 1983; Watson et al., 1973; White and Templeton, 1992] . We describe a case of chemical pneumonitis following use of a household cleaning agent containing HF. To our knowledge, pulmonary injury associated with use of a household product containing HF has not been reported.
CASE REPORT
A previously healthy 26-year-old woman used multiple household products in an attempt to remove a stain from a bathtub (see Table I for details on product contents). She had a past medical history of ''walking pneumonia'' diagnosed without confirmatory chest radiograph a year preceding this illness, and a 13-year history of semiannual episodes of acute bronchitis. All these illnesses had resolved with antibiotic therapy. She also smoked 1.5 packs of cigarettes a day for the same 13 years. Her occupational history was unremarkable for significant pulmonary expo-sures: she had not been working for 2 months preceding her illness and had previously been an in-house care giver. She did not use any medications. She was 178 cm tall and weighed 115 kg.
The tub was located in a small bathroom (approximately 5 3 7 3 7 feet) with no ventilation other than a heating vent. It was late fall, and the only window was sealed shut with plastic. The door to the bathroom was kept closed when cleaning the tub. At no time did she mix different products, and she always rinsed the tub with cold water before applying each different product. She wore no gloves, using an Ajax t pad initially and thereafter a stiff, long-handled brush.
On day 1, she used Comet t and an Ajax t pad, then 10 oz of X-14 Mildew Stain Remover t . On day 2, she tried 32 oz of The Works Tub and Tile Cleaner t ; this was followed by 8 oz of ammonia. After the usual cold water rinse, she next plugged the drain and poured in a gallon of liquid bleach, then adding cold water. She let this sit for several minutes before allowing to drain. On day 3, she applied 16 oz of Sno-bol t . She next applied 16 oz of white vinegar. Later, she applied a half-gallon of liquid bleach. As stated above, each application was followed by a cold water rinse. She and the other household residents did not recall any symptoms of mucous membrane irritation up to this point in time.
At 10 PM on day 3, she applied 10 oz of Whink Rust Remover t over an estimated 30 minute interval. During this application she experienced burning and tearing to both eyes and a foul taste to her mouth; she did not recall experiencing any upper or lower respiratory symptoms at that time. However, two other household members who both used the bathroom shortly after she applied Whink Rust Remover t recalled experiencing strong, almost unbearable eye, nose and throat irritation.
Following the initial application, she went to a store and obtained 2 more 10-oz bottles of Whink Rust Remover t , which she applied over an additional estimated 30-min interval that same evening. During the second application of Whink t she experienced a burning sensation to the eyes and a foul taste to her mouth (the latter persisted until breakfast the following morning). She did not experience any dermal burns.
On day 4, the patient was ''sleepy'' and remained in bed much of the day; she did not recall experiencing respiratory symptoms through day 4. She awoke earlier than usual the morning of day 5 with right lateral chest pain, shortness of breath, and a nonproductive cough. She had not yet experienced any fever, chills or sweats.
Before 8 AM on day 6, she was seen in the emergency department of a local hospital. Her vitals signs were remarkable for a respiratory rate of 28/min and a temperature of 36.2°C. Auscultation revealed rales and wheezes over the right chest. The white blood cell (WBC) count was 14,000 with a normal differential; arterial blood (ABG) gas values were unremarkable. A chest radiograph showed a right lower lobe infiltrate. Refusing admission, she was prescribed cephalexin monohydrate and ibuprofen and sent home.
She returned to the same hospital and was admitted the evening of day 7, complaining of severe right shoulder pain, increased nonproductive cough, orthopnea, fevers, and chills. Her vital signs were recorded as temperature 35.3°C, pulse 100, blood pressure 110/80, and respirations 40/min. Her nose and throat were documented as ''clear.'' Auscultation revealed diffuse rhonchi and wheezing over both lungs. The leukocyte count was 13,000 with 76% segmentals, 15% lymphocytes, 7% monocytes, and 2% eosinophils. A repeat chest radiograph again demonstrated a right lower lobe infiltrate. Treatment was continued with cephalexin monohydrate and oxygen.
On day 8, electrolytes, blood urea nitrogen (BUN), and creatinine were normal. The leukocyte count was 14,000 with a normal differential. A chest radiograph obtained at 4:08 PM showed loss of the right heart border, with infiltrate involving all lobes except the right upper lobe. At 5 PM she was transferred to the coronary care unit (CCU), where she was diuresed 2 L with Lasix and was started on erythromycin, clarithromycin, cefuroxime sodium, and methylprednisolone sodium succinate (60 mg IV q6h). Her respiratory rate reached 45/min, and she was intubated later the same evening.
At 1 AM of day 9, she experienced a sudden decrease in oxygenation, requiring 100% O 2 , and 10 cm H 2 O of peak end-expiratory pressure (PEEP) to maintain oxygen saturation above 70%. Later on day 9, she was transferred to the University of Michigan Medical Center (UMMC). She remained on methylprednisolone sodium succinate 60 mg q6h through the morning of day 10; then she received 1 g of methylprednisolone sodium succinate each day for 3 more days. She was kept on erythromycin and began ceftriaxone and gentamycin. She was maintained on antibiotic therapy for the remaining 28 days of her admission at UMMC.
She experienced fevers of ,38.3°C on day 9 and several times during the next 2 weeks. Bronchoscopy with brushings and lavage, accomplished on day 9, was consistent with alveolar hemorrhage. Stains and cultures for She was extubated on day 25 but remained hospitalized for treatment of a deep venous thrombosis and heme positive stools through day 36. One month after discharge, she had a persistent, nonproductive nocturnal cough and dyspnea on climbing one flight of stairs; she had not resumed smoking. Pulmonary function test results were consistent with mixed mild restrictive disease and with mild to moderate obstruction in small airways (Table II) .
No measurements of serum calcium were performed at the outside hospital. Serum calcium was measured at UMMC on day 9, 6 days after exposure to the Whink t , and was normal.
DISCUSSION
This patient experienced hemorrhagic alveolitis and adult respiratory disease syndrome (ARDS). The etiological factor from her history that best explains the etiology of her illness is her exposure to HF. There is reason to believe her inhalational exposure to HF was adequate to initiate the injury, and there is evidence to support a proposed mechanism for such an injury.
To summarize the case history, the patient experienced immediate irritant symptoms following use of an HFcontaining product to clean her bathtub. Within 2.5 days, she was documented to have cough, chest pain, and a right lower lobe infiltrate on chest radiography. After 2.5 more days, while on oral and then intravenous antibiotic therapy, her condition worsened with the development of ARDS, requiring prolonged mechanical ventilatory support. Early bronchoscopy (day 9) showed the presence of hemmorrhagic alveolitis. Upon recovery she was left with a residual mixed restrictive/obstructive pulmonary deficit.
Although it is possible that the patient's pathology was caused by a biological or chemical agent other than HF, HF remains the most likely causative factor. The patient had no recent history of exposure to illness. Testing and cultures for a biological cause were negative, and she did not respond to antiobiotic therapy. Although the early chest radiographs showed a focal lesion suggestive of an infectious agent, such focal lesions have been found to occur in animal subjects exposed to HF Stokinger, 1949] . The exposure in this case was of an intensity closer to that of those animal subjects than to the massive exposures described in most recorded human inhalation injuries. Additionally, focal pneumonias are a known complication of HF inhalational injury in animal subjects . Also, given the lower intensity of HF exposure experienced by the patient, it is possible that her ARDS evolved more slowly than has been recorded among cases with massive, overwhelming exposure.
It is doubtful that the non-HF cleaning agents contributed to the patient's pulmonary injury. The cold water rinse between her use of ammonia hydroxide and her use of sodium hypochlorite on day 2 would have prevented the formation of chloramines [Reisz and Gammon, 1986] . The patient specifically denied ever mixing any of the different cleaning agents. Further, neither the patient nor the other household occupants recalled experiencing irritation on exposure to any of the non-HF containing products. And, the chemical agents in the non-HF products would not be expected to cause delayed-onset chemical pneumonitis as is known to occur following exposure to HF [Braun et al., 1984] .
Although HF exposure levels experienced by the patient were not measured, Whink Rust Remover t contains only 8% HF. It has been suggested that inhalation hazard may not exist in solutions containing less than 60% HF [Mayer and Guelich, 1963] . Other publications suggest inhalation injury due to HF in the absence of massive sudden exposure or entrapment is unlikely. It is thought that the noxious effects of gaseous HF at concentrations adequate to induce pulmonary insult would drive exposed individuals away before significant injury could occur [White and Templeton, 1992] . These opinions appear to have been derived from experience with brief, immediately life-threatening industrial exposures rather than more prolonged and moderate exposures. The exposure experienced by our patient had several unique features that suggest a mechanism whereby she could have experienced an unsafe exposure to HF, which produced a more delayed, rather than an immediate, clinical response. The patient was working in a small, unventilated room, and she used 3 full bottles of Whink t in a short interval. Further, she was physically active, scrubbing the HFcontaining product in a bathtub. The scrubbing action would have promoted aerosolization of the HF solution; it would also have generated some heat, increasing the volatilization of the HF. As HF and mist are heavier than air, and as no significant ventilation was present, these would have been at a greater concentration within the bathtub itself. The patient was working with her head directly over or even partially within the bath tub, so she would have inhaled this higher concentration of HF and HF-containing aerosol. Additionally, her physical activity would have increased the rate and depth of her respirations and would have predisposed her to mouth breathe.
Many human nose breathers will mouth breath during physical activity [Stavert et al., 1991] . Exercise and oronasal and oral breathing have been associated with increased penetration of highly water soluble chemicals to the deep lung [Dungworth, 1989; Miller et al., 1989] . In bypassing the nasal passageways, a significant protective mechanism of the lungs is eliminated. HF gas would normally (i.e., in the absence of physical activity) be expected to deposit in the human nasal passageways preferentially for several reasons. Gaseous HF is infinitely soluble in cold water [Handbook of Chemistry and Physics, 1978] , and it has been observed that gases with higher solubility tend to be scavenged effectively by the upper respiratory mucosa, causing upper respiratory injury. Intermediately soluble, and highly insoluble toxic gases tend to have their effect on the lower respiratory mucosa [Reisz and Gammon, 1986; White and Templeton, 1992; Morris and Smith, 1982; Stavert et al., 1991; Dungworth, 1989; Miller et al., 1989] . Additionally, more reactive compounds are thought to be more effectively scavenged in the upper airways, and HF is very reactive at physiological pH, being a weak acid (pK 3.45).
Once in contact with lung tissue, HF would most probably cause cell injury via the same two mechanisms thought to cause damage in dermal exposures: first, by acting as a weak acid; and second, by formation of fluoride salts with intracellular calcium and magnesium-leading to cell death [MacKinnon, 1988] .
The delay between exposure and pulmonary symptoms in the case we describe is consistent with reported HF inhalation injuries. With massive HF exposures, pulmonary injury was evident in a man who died within 30 minutes of exposure [Watson et al., 1973] . However, intraluminal exudate can be most severe 2-3 days after exposure to a reactive gas [Dungworth, 1989; Miller et al., 1989] . And, death secondary to inhalation of HF has been reported to occur days to weeks after injury [Braun et al., 1984] . We hypothesize that with massive exposure the primary mechanism of tissue injury is related to the acid properties of HF. At lower levels of exposure, and if the patient survives the effects of the acidic insult, salt formation by fluoride ions may become more important in determining local pulmonary tissue damage. In the present case exposure was not overwhelming, but we believe it was adequate for the fluoride ion to produce serious pulmonary injury.
That the patient was exposed to HF capable of causing her pulmonary injury is further supported by the symptoms experienced by herself and the other two adult occupants of the house. She experienced a foul taste and eye irritation but does not recall experiencing the nose and throat irritation experienced by the other two adults, who visited the bathroom near the time of the Wink t product application. All four of these symptoms have been documented to occur at HF concentrations as low as 12.1 ppm HF . A foul taste, described as flat and sour by Machle, has been reported to occur at levels at least as low as 5.9 ppm [Largent, 1961] .
That the patient did not recall having experienced the irritation described by the other two adults might be accounted for by the known difference in symptoms experienced by different subjects at specific concentrations of HF [Largent, 1961] . However, the other two adults had exposures of only a few minutes, a fraction of the time experienced by the patient; with her more prolonged exposure, she may have become acclimatized to the HF. Such an acclimatization has been well documented in human studies [Collings et al., 1951] . Acclimatization to HF has been further confirmed in a study where animals exposed to 23.3 ppm HF were observed to experience mild respiratory tract irritation which decreased after 5-15 min, when the animals developed a mucoid discharge .
Whether or not acclimatization occurred, a concentration of 7.1 ppm HF has been determined to be ''tolerable and respirable'' in one human study involving brief exposures, and higher concentrations were felt to be sufficiently irritating as to discourage prolonged human exposure . The question of whether an exposure to 7.1 ppm HF could cause pulmonary injury in an exposure similar to that experienced by the patient in this paper is not answered by the human studies cited in this paper. However, animal studies suggest a potential for injury. Stokinger [1949] found moderate hemorrhage and edema in the lungs of 3 of 4 dogs exposed to 11.6 ppm HF gas for 6 hr/day over a 5-week period and that 1 of 5 dogs exposed to 3.3 ppm had a focal area of pulmonary hemorrhage. At lethal levels, death resulted from pulmonary damage, and at nonlethal levels, if any damage occurred it was most frequently pulmonary damage. exposed 1 Rhesus monkey, 5 rabbits, and 3 guinea pigs to 7.08 ppm HF for 6 or 7 hr/day for 50 days (excluding weekends) for a total 309-hr exposure. The monkey suffered renal damage, but had no pulmonary lesions. One guinea pig died after a 134-hr exposure and was found to have a ''low-grade inflammatory reaction in the alveolar walls with atelectasis, and pronounced degenerative changes and hyperplasia of the bronchial epithelium.'' A second guinea pig died at 160 hr and was found to have ''a large, partly organized pulmonary hemorrhage with low-grade cellular reaction.'' The third guinea pig was sacrificed 9 months after exposure and was found to have organized pulmonary hemorrhages, alveolar exudates, and cellular infiltrations of the alveolar walls with irregular thickening. All four exposed rabbits had evidence of pulmonary damage in the form of leukocytic infiltration of the alveolar walls, with or without edema or thickening, and their lungs were unlike those of the control rabbits. Bronchopneumonia was the major cause of delayed death in these animal subjects, especially among the rabbits.
While both Stokinger's and Machle's studies involved much longer durations of exposure than that experienced by the patient, concentrations that were shown to be injurious to animals were below those described by Machle as ''tolerable and respirable'' and at which ''chronic human exposure could easily occur'' ].
CONCLUSION
The patient described in this report suffered hemorrhagic alveolitis and ARDS following use of a household cleaning product containing 8% hydrofluoric acid. The timing, circumstances of exposure, and clinical features of her illness would suggest HF as the cause of her illness. In our opinion, the presence of HF in a consumer product may be unduly hazardous.
